跳至主要内容
临床试验/NCT01534000
NCT01534000已完成不适用

Cardiac-CT in the Treatment of Acute Chest Pain

Hvidovre University Hospital2 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
600
试验地点
2
主要终点
combined endpoint of: Cardiac death, myocardial infarction, unstabile angina, revascularisation, readmissions for chest pain

研究概览

简要总结

Objectives The CATCH trial (CArdiac cT in the treatment of acute CHest pain) is a prospective randomized controlled trial designed to evaluate the clinical value of cardiac multidetector computed tomography (MDCT) as a first-line diagnostic strategy in patients with acute chest pain, compared to a conventional functional-based testing strategy.

Methods:

Consecutive patients admitted with acute chest pain of suspected cardiac origin, but normal electrocardiogram and biomarkers were randomized to evaluation with 320-MDCT coronary angiography (CT-guided group) or with standard bicycle exercise test and/or myocardial perfusion imaging - MPI (Control group).

After one year, patients will be followed-up, with registration of clinical endpoints such as Cardiac death, myocardial infarction, need for revascularisation, admittance for heart related problems, sustained chest pain, live quality score, use of medication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admittance because of Chest pain
  • Non- or non-diagnostic ecg-changes.
  • Normal biomarkers for ischemia (Troponins)
  • Chest X-ray without pathological findings associated with chest pain.

排除标准

  • Women of childbearing age, or > 40 years and using approved contraception.
  • Claustrophobia
  • Patients with geographical residence, that complicates follow-up
  • Patients with mental or physical conditions that impede follow-up
  • Increase in Troponins
  • New diagnostic ECG changes with ST-segment elevation or depression greater than 1mm or T-yew inversion> 4 mm in> 2 anatomically connected derivations.
  • Allergy to iodinated contrast agents
  • Serum creatinine greater than 130 mg/l
  • Abnormal chest x-ray or blood tests hospitalization as assessed as the main cause of the patient's pain problem.

结局指标

主要结局

combined endpoint of: Cardiac death, myocardial infarction, unstabile angina, revascularisation, readmissions for chest pain

时间窗: 1 year follow-up

次要结局

  • Cardiac death(1 year follow-up)
  • myocardial infarction(1 year follow-up)
  • readmissions for chest pain(1 year follow-up)
  • Revascularisation(1 year follow-up)
  • unstabile angina(1-year follow-up)
  • continued chest pain(1 year follow-up)
  • downstream testing(1-year follow-up)
  • Quality of life (SF-36)(1-year follow-up)
  • medication(1-year follow-up)
  • non-cardiac findings on CT(1-year follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jens D Hove, MD,PHD

Chief of Cardiac CT, MD,PHD

Hvidovre University Hospital

研究点 (2)

Loading locations...

相似试验